Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

147.00p
   
  • Change Today:
      2.00p
  • 52 Week High: 149.00
  • 52 Week Low: 87.00
  • Currency: UK Pounds
  • Shares Issued: 84.77m
  • Volume: 51,169
  • Market Cap: £124.62m
  • RiskGrade: 196

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
54.09% above the market average54.09% above the market average54.09% above the market average54.09% above the market average54.09% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
25.30% above the market average25.30% above the market average25.30% above the market average25.30% above the market average25.30% above the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average
Price Book Ratio
62.77% below the market average62.77% below the market average62.77% below the market average62.77% below the market average62.77% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
88.11% above the market average88.11% above the market average88.11% above the market average88.11% above the market average88.11% above the market average
63.16% above the sector average63.16% above the sector average63.16% above the sector average63.16% above the sector average63.16% above the sector average
Price Chg 3m
65.21% above the market average65.21% above the market average65.21% above the market average65.21% above the market average65.21% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
97.75% above the market average97.75% above the market average97.75% above the market average97.75% above the market average97.75% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Momentum 20
82.99% above the market average82.99% above the market average82.99% above the market average82.99% above the market average82.99% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
51.28% below the market average51.28% below the market average51.28% below the market average51.28% below the market average51.28% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
64.25% below the market average64.25% below the market average64.25% below the market average64.25% below the market average64.25% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
17.6% below the market average17.6% below the market average17.6% below the market average17.6% below the market average17.6% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average
Operating Profit Loss
61.45% below the market average61.45% below the market average61.45% below the market average61.45% below the market average61.45% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
1.65% above the market average1.65% above the market average1.65% above the market average1.65% above the market average1.65% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average
Cash
24.81% above the market average24.81% above the market average24.81% above the market average24.81% above the market average24.81% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
51.25% above the market average51.25% above the market average51.25% above the market average51.25% above the market average51.25% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Buys 1y
2.86% below the market average2.86% below the market average2.86% below the market average2.86% below the market average2.86% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 147.00p
Change Today 2.00p
% Change 1.38 %
52 Week High 149.00
52 Week Low 87.00
Volume 51,169
Shares Issued 84.77m
Market Cap £124.62m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.09% below the market average39.09% below the market average39.09% below the market average39.09% below the market average39.09% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average
Price Trend
89.13% above the market average89.13% above the market average89.13% above the market average89.13% above the market average89.13% above the market average
94.74% above the sector average94.74% above the sector average94.74% above the sector average94.74% above the sector average94.74% above the sector average
Income Not Available
Growth
21.65% above the market average21.65% above the market average21.65% above the market average21.65% above the market average21.65% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Diaceutics Dividends

No dividends found

Trades for 17-Jan-2025

Time Volume / Share Price
15:34 10,165 @ 147.50p
14:34 6,000 @ 146.00p
13:29 10,000 @ 147.00p
12:58 8,789 @ 147.90p
12:16 334 @ 147.90p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page